Additional information: the device was not available; therefore, product testing on the actual device could not be performed.The device identifiers were not provided; therefore, the device history records for this device lot number could not be reviewed.A review of the device labeling was completed.Corneal edema and malpositioned stent are identified in the labeling as known inherent risks of trabecular micro-bypass stent procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.An adverse event appears to have occurred, but does not appear to have been a problem with the device or the way it was used.Each reported event is an established risk associated with use of the device, which is clearly specified in the products' labeling.Based on the information received, the root cause of the reported event could not be conclusively identified.Mfr# reference: (b)(4).
|
It was reported that following a cataract plus trabecular microbypass stent system procedure, the patient presented postoperatively with the stent visible in the cornea, sitting securely without perforating the cornea.Through follow-up, the surgeon consulted with expert opinion md who reported discussing that the stent may actually be in the peripheral cornea without concern.Discussion also included a report of patients corneal edema and subsequent treatment options based on the patients' condition.Additional information has been requested.
|